Best Practice & Research Clinical Rheumatology
Volume 22, Issue 4 , Pages 741-757 , August 2008

Complementary and alternative practices in rheumatology

  • Cesar Ramos-Remus, MD, MSc (Director, UIECD, Professor of Rheumatology, Universidad de Guadalajara, and Attending Rheumatologist at Hospital General Regional 45, IMSS Guadalajara, México)

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +52 33 38 17 63 35.

References 

  1. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer. Cancer. 1998;83:777–782
  2. Verhoef MJ, Sutherland LR, Brkich L. Use of alternative medicine by patients attending a gastroenterology clinic. Canadian Medical Association Journal. 1990;142:121–125
  3. Moody GA, Eaden JA, Bhakta P, et al. The role of complementary medicine in European and Asian patients with inflammatory bowel disease. Public Health. 1998;112:269–271
  4. Wainapel SF, Thomas AD, Kahan B. Use of alternative therapies by rheabilitation outpatients. Archives of Physical Medicine and Rehabilitation. 1998;79:1003–1005
  5. Cohen CJ, Eisenberg DM, Mayer KH, Delblanco TL. Prevalence of alternative medical treatments in HIV-infected patients: implications for primary care. [abstract] Clinical Research. 1990;38:692
  6. McGinnis LS. Alternative therapies, 1990: an overview. Cancer. 1991;67:1788–1792
  7. Smart HLA, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut. 1986;27:826–828
  8. Singh P, Yadav RJ, Pandey A. Utilization of indigenous systems of medicine & homeopathy in India. Indian Journal of Medical Research. 2005;122:137–142
  9. Kronenfeld JJ, Wasner C. The use of unortodox therapies and marginal practitioners. Social Science & Medicine. 1982;16:1119–1125
  10. Cronan TA, Kaplan RM, Kozin F. Factors affecting unprescribed remedy use among people with self-reported arthritis. Arthritis Care and Research. 1993;6:149–155
  11. Chandrashekara S, Anilkumar T, Jamuna S. Complementary and alternative therapy in arthritis. The Journal of the Association of Physicians of India. 2002;50:225–227
  12. Zaman T, Agrawal S, Handa R. Complimentary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre. National Medical Journal of India. 2007;20:236–239
  13. Tembe AG, Kharbanda P, Bhojani K, Joshi VR. Profile of rheumatoid arthritis patients: a questionnaire based study from a private hospital. [abstract] Indian Journal of Rheumatology. 2007;2:S17
  14. Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care and Research. 1996;9:13–17
  15. Lind BK, Lafferty WE, Tyree PT, et al. Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis and Rheumatism. 2007;57:71–76
  16. Ramos-Remus C, Watters CA, Dyke L, et al. Assessment of health locus of control in the use of non-conventional remedies by patients with rheumatic diseases. The Journal of Rheumatology. 1999;26:2468–2474
  17. Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, et al. Use of non-conventional therapies by patients with rheumatic diseases in Guadalajara, Mexico: prevalence, beliefs and expectations. Arthritis Care and Research. 1998;11:411–418
  18. Singh V, Raidoo DM, Harries CS. The prevalence, patterns of usage and people's attitude towards complementary and alternative medicine (CAM) among the Indian community in Chatsworth, South Africa. BMC Complementary and Alternative Medicine. 2004;4:3
  19. Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, Suarez-Almazor ME. Use of alternatiave medicine in a consecutive sample of patients with systemic lupus erythematosus. The Journal of Rheumatology. 1997;24:2490–2491
  20. Gordon NP, Sobel DS, Tarazona EZ. Use of and interest in alternative therapies among adult primary care clinicians and adult members in a large health maintenance organization. Western Journal of Medicine. 1998;169:153–161
  21. Borkan J, Neher J, Anson O, Smoker B. Referrals for alternative therapies. The Journal of Family Practice. 1994;39:545–550
  22. Varma U, Sharma R, Gupta P, et al. Allopathy v/s Ayurvedic practices in tertiary care institutions of urban north India. Indian Journal of Pharmacology. 2007;39:52–54
  23. Verhoef MJ, Sutherland LR. Alternative medicine and general practitioners. Canadian Family Physician. 1995;41:1005–1011
  24. Wharton R, Lewith G. Complementary medicine and the general practitioner. BMJ (Clinical Research Ed.). 1986;292:1498–1500
  25. Himmel W, Schulte M, Kochen MM. Complementary medicine: are patients' expectations being met by their general practitioners?. The British Journal of General Practice. 1993;43:232–235
  26. Ernst E, Kaptchuk TJ. Complementary medicine – the case for dialogue. Journal of the Royal College of Physicians of London. 1996;30:410–412
  27. van Haselen RA, Reiber U, Nickel I, et al. Providing complementary and alternative medicine in primary care: the primary care workers' perspective. Complementary Therapies in Medicine. 2004;12:6–16
  28. Widmer M, Herren S, Dönges A, et al. Complementary and conventional medicine in Switzerland: comparing characteristics of general practitioners. Forschende Komplementärmedizin. 2006;13:234–240
  29. Giannelli M, Cuttini M, Da Frè M, Buiatti E. General practitioners' knowledge and practice of complementary/alternative medicine and its relationship with life-styles: a population-based survey in Italy. BMC Family Practice. 2007;15(8):30
  30. Cohen MM, Penman S, Pirotta M, Da Costa C. The integration of complementary therapies in Australian general practice: results of a national survey. Journal of Alternative and Complementary Medicine (New York, N.Y.). 2005;11:995–1004
  31. Berman BM, Bausell RB, Lee WL. Use and referral patterns for 22 complementary and alternative medical therapies by members of the American College of Rheumatology: results of a national survey. Archives of Internal Medicine. 2002;162:766–770
  32. Astin JA. Why patients use alternative medicine. The Journal of the American Medical Association. 1998;279:1548–1553
  33. Bernstein JH, Shuval JT. Nonconventional medicine in Israel: consultation patterns of the Israeli population and attitudes of primary care physicians. Social Science & Medicine. 1997;44:1341–1348
  34. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. The New England journal of medicine. 1993;328:246–252
  35. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. The Lancet. 1996;347:569–573
  36. Millar WJ. Revue Canadienne de Sante Publique. 1997;88:154–158
  37. Verhoef MJ, Russell ML, Love EJ. Alternative medicine use in rural Alberta. Revue Canadienne de Sante Publique. 1994;85:308–309
  38. Boisset M, Fittzcharles MA. Alternative medicine use by rheumatic patients in a universal health care setting. The Journal of Rheumatology. 1994;21:148–152
  39. McGinnis JM, Foege WH. Actual causes of death in the United States. The Journal of the American Medical Association. 1993;270:2207–2212
  40. Callahan LF, Pincus T. Education, self-care, and outcomes of rheumatic diseases: further challenges to the ‘biomedical model’ paradigm. Arthritis Care and Research. 1997;10:283–288
  41. Ramos-Remus C, Salcedo-Rocha AL, Prieto-Parra R, Galvan-Villegas F. How important is patient education?. Baillière's Best Practice & Research Clinical Rheumatology. 2000;14:689–703
  42. Ries A, Trout J. Positioning: the battle for your mind. McGraw-Hill; 2000;
  43. Lynch N, Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complementary Therapies in Medicine. 2007;15:84–91
  44. Barnes J, Mills SY, Abbot NC, et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. British Journal of Clinical Pharmacology. 1998;45:496–500
  45. Aceves FJ, Medina F, Fraga A. Herbal therapies in rheumatology: the persistence of ancient medical practices. Clinical and Experimental Rheumatology. 2001;19:177–183
  46. Lee GB, Charn TC, Chew ZH, Ng TP. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Family Practice. 2004;21:654–660
  47. Chao MT, Wade C, Kronenberg F, et al. Women's reasons for complementary and alternative medicine use: racial/ethnic differences. Journal of Alternative and Complementary Medicine (New York, N.Y.). 2006;12:719–720
  48. Vandebroek I, Thomas E, Sanca S, et al. Comparison of health conditions treated with traditional and biomedical health care in a Quechua community in rural Bolivia. Journal of Ethnobiology and Ethnomedicine. 2008;4:1
  49. Barlow JH, Macey SJ, Struther GR. Gender, depression and ankylosing spondylitis. Arthritis Care and Research. 1993;6:45–51
  50. Wallston KA, Wallston BS, Kaplan G, Maides S. Development of the multidimensional health locus of control (MHLC) scales. Health Education Monographs. 1978;6:160–170
  51. Gawande A. Annals of medicine: the way we age now. The New Yorker. April 30, 2007;50–59
  52. Suarez-Almazor ME, Kendall CJ, Dorgan M. Surfing the net- information on the World Wide Web for persons with arthritis: patient empowerment or patient deceit?. The Journal of Rheumatology. 2001;28:185–191
  53. van Winkelen P, van Dendersen JS, Vossen CY, et al. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?. Rheumatology (Oxford, England). 2006;45:1154–1157
  54. Bubela T, Koper M, Boon H, Caulfield T. Media portrayal of herbal remedies versus pharmaceutical clinical trias: impacts on decision. Medicine and Law. 2007;26:363–373
  55. Weeks L, Verhoef M, Scott C. Presenting the alternative: cancer and complementary and alternative medicine in the Canadian print media. Support Care Cancer. 2007;15:931–938
  56. Jarvis WT. Quackery: the National Council against health fraud perspective. Rheumatic Diseases Clinics of North America. 1999;25:805–814
  57. Ramos-Remus C, Gutierrez-Ureña S, Davis P. Epidemiology of complementary and alternative practices in rheumatology. Rheumatic Diseases Clinics of North America. 1999;25:789–804
  58. Ramos-Remus C, Aceves Avila FJ. Enfermedades reumáticas: ¿Un mismo problema para el paciente y el reumatólogo. Revista Mexicana De Reumatología. 2003;18:S14
  59. Suarez-Almazor ME, Berrios-Rivera JP, Cox V, et al. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantage patients with rheumatoid arthritis. The Journal of Rheumatology. 2007;34:2400–2407
  60. Aceves-Avila FJ, Ferrari R, Ramos-Remus C. New insights into culture driven disorders. Best Practice & Research Clinical Rheumatology. 2004;18:155–171
  61. Yu WY, Shen SW, Yang ZH. A clinical study of Sougudan granule in the treatment of rheumatoid arthritis. Chinese Journal of Integrative Medicine. 2005;11:255–259
  62. Zhang GG, Lee W, Bausell B, et al. Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis. Journal of Alternative and Complementary Medicine (New York, N.Y.). 2005;11:415–421
  63. Zhang GG, Lee WL, Lao L, et al. The variability of TCM pattern diagnosis and herbalprescription on rheumatoid arthritis patients. Alternative Therapies in Health and Medicine. 2004;10:58–63
  64. He Y, Lu A, Zha Y, et al. Correlations between symptoms as assessed in traditional chinece medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western Medicine. Journal of Clinical Rheumatology. 2007;13:317–321
  65. Li EK, Tam LS, Wong CK, et al. Safety and efficacy of Ganoderma lcidum(lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis and Rheumatism. 2007;57:1143–1150
  66. Boutron I, Tubach F, Giraudeau B, Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. The Journal of the American Medical Association. 2003;290:1062–1070
  67. Cook C, Baisden D. Ancillary use of folk medicine by patients in primary care clinics in Southwestern West Virginia. Southern Medical Journal. 1986;79:1098–1101
  68. Fisher P, Ward A. Complementary medicine in Europe. BMJ (Clinical Research Ed.). 1994;309:107–110
  69. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Annals of Internal Medicine. 1992;117:129–132
  70. Lawrence RC, Helmick Ch G, Arnett F, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis and Rheumatism. 1998;41:778–799
  71. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. Journal of Clinical Gastroenterology. 1990;12:203–206
  72. Mohabbat O, Younos MS, Merzad AA, et al. An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet. 1976;2:269–271
  73. Davis C. Risks of manipulation. Journal of the Royal Society of Medicine. 1994;87:182
  74. Borins M. The dangers of using herbs. Postgraduate Medicine. 1998;104:91–100
  75. Ernst E. Harmless herbs? A review of the recent literature. American Journal of Medicine. 1998;104:170–178
  76. Gertner E, Marshall PS, Filandrinos D, et al. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis and Rheumatism. 1995;38:614–617
  77. Goldman JA. Chinese herbal medicine: camouflaged prescription antiinflammatory drugs, corticosteroids, and lead. Arthritis and Rheumatism. 1991;34:1207
  78. Ries CA, Sahud MA. Agranulocytosis caused by Chinese herbal medicines: dangers of medications containing aminopyrine and phenylbutazone. The Journal of the American Medical Association. 1975;231:352–355
  79. Huang WF, Wen K-C, Hsiao M-L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. Journal of Clinical Pharmacology. 1997;37:344–350
  80. Yu H, Zhong S, Chan K, et al. Pharmacognostical investigations on traditional Chinese medicinal herbs. The Journal of Pharmacy and Pharmacology. 1995;47:1129–1131
  81. Cui J, Garle M, Eneroth P, Björkhem I. What do commercial ginseng preparations contain?. The Lancet. 1994;344:134
  82. Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. The Journal of Rheumatology. 2002;29:2407–2409
  83. Draves AH, Walker SE. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations. The Canadian Journal of Clinical Pharmacology. 2003;10:114–118
  84. Ko RJ. Adulterants in Asian patent medicines. The New England Journal of Medicine. 1998;339:847
  85. Miller GM, Tripp R. A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown. Legal Medicine (Tokyo, Japan). 2007;9:258–264
  86. Espinoza EO, Mann M-J. Arsenic and Mercury in traditional Chinese herbal balls. The New England Journal of Medicine. 1995;33:803–804
  87. Obt AB, Oh JY, Huntington RA, Burkhart KK. Chinese herbal medicine induces acute renal failure. Archives of Internal Medicine. 1995;155:211–212
  88. But PP. Herbal poisoning caused by adulterants or erroneous substitutes. The Journal of Tropical Medicine and Hygiene. 1994;97:371–374
  89. Slifman N, Obermeyer WR, Aloi BK, et al. Contamination of botanical dietary supplements by digitalis lanata. The New England Journal of Medicine. 1998;339:806–811
  90. Cooper K, Noller B, Connell D, et al. Public health risks from heavy metals and metalloids present in traditional Chinese medicines. Journal of Toxicology and Environmental Health. Part A. 2007;70:1694–1699
  91. Shaw D, Leon Ch, Kolev S, Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991–1995). Drug Safety. 1997;17:342–356
  92. DiPaola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. The New England Journal of Medicine. 1998;339:785–791
  93. Pietroni PC. Beyond the boundries: relationship between general practice and complementary medicine. BMJ (Clinical Research Ed.). 1992;305:564–566
  94. Thomas KJ, Carr J, Westlake L, Williams BT. Use of non-orthodox and conventional healthcare in Britain. British Medical Journal. 1991;302:207–210
  95. Oldendick R, Coker AL, Wieland D, et al. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research Team. Southern Medical Journal. 2000;93:375–381
  96. Panush RS. Reflections on unproven remedies. Rheumatic Diseases Clinics of North America. 1993;19:201–206
  97. Busato A, Dönges A, Herren S, et al. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland–an observational study. Family Practice. 2006;23:116–124
  98. Coopes MJ, Anderson RA, Egeler RM, Wolff JE. Alternative therapies for the treatment of childhood cancer. The New England Journal of Medicine. 1998;339:846
  99. Barnes J. Pharmacovigilance of herbal medicines: a UK perspective. Drug Safety. 2003;26:829–851
  100. British Medical Association . Complementary medicine: new approaches to good practice. Oxford: Oxford University Press; 1993;
  101. Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-based Complementary and Alternative Medicine. 2005;2:465–473
  102. Available from http://indianmedicine.nic.in/html/ayurveda/afmain.htm
  103. Vaidya AB. Effective Integration of Indian Systems of Medicine in Health Care delivery: People's participation, Access and Choice in a Pluralistic Democracy, Financing and Delivery of healthcare services in India, National Commission on Macroeconomics and Health, Ministry of Health & Family Welfare, Government of India, New Delhi, August 2005. p. 77–87.
  104. Vaidya ADB. Reverse pharmacological correlates of ayurvedic drug actions. Indian Journal of Pharmacology. 2006;38:311–315
  105. Ashwinikumar A. Raut, Ashok D.B.Vaidya. Reverse pharmacology: application to ayurvedic medicine. In: Proceedings of second national seminar on evidence based and integrated medicine for lymphatic filariasis, other chronic dermatoses and HIV/AIDS, Kasargod, Kerala, S. India; February 2007. p. 47–52.
  106. Raut AA, Sarkar S, Sudha S, et al. Commiphora wightii (Guggulu) induced downregulation of macrophage released cytokines in vitro. Indian Drugs. 2007;44:39–42
  107. Singh BB, Mishra LC, Vinjamury SP, et al. The effectiveness of Commiphora mukul for osteoarthritis of the knee – an outcome study. Alternative Therapies in Health and Medicine. 2003;3:74–79
  108. Deodhar SD, Sthi R, Srimal RC. Preliminary study on antirheumatic activity of Curcumin (diferulolyl methane). Indian Journal of Medical Research. 1980;71:632–634
  109. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: a double blind, placebo-controlled, cross-over study. Journal of Ethnopharmacology. 1991;33:91–95
  110. White B. Ginger an overview. American Family Physician. 2007;75:1689
  111. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis and Rheumatism. 2001;44:2531
  112. Chopra A, Raut A, Bichile L, et al. A Controlled Drug Trial to Evaluate Ayurvedic Derived Shunthi-Guduchi Based Standard Formulations in the Treatment of Osteoarthritis (OA) Knees: a Government of India NMITLI Arthritis Project. [abstract] Annals of the Rheumatic Diseases. 2006;65(Suppl. 11):226–227
  113. Chopra A, Narsimulu G, Bichile L, et al. Comparing ayurvedic (India) herbal drugs and HCQS (hydroxychloroquin sulphate) in the treatment of rheumatoid arthritis (RA): randomized, double blind, multi-centric exploratory drug trial of 24 weeks duration. [abstract] Arthritis and Rheumatism. 2007;56(Suppl. 9):S394–S395
  114. Raut AA, Sawant NS, Badre AS, et al. A controlled drug trial to evaluate ayurvedic derived Shunthi-Guduchi based standard formulations in the treatment of kar, A.D.B. Vaidya. Bhallatak (Semecarpus anacardium Linn) – a review. Indian Journal of Traditional Knowledge. 2007;6:653
  115. Bajpai HS, Sathyavati GV, Agrawal U, et al. Role of Semecarpus anacardium Linn (Bhallatak) in the treatment of arthropathies – a preliminary report. The Journal of Research in Indian Medicine. 1970;5:1
  116. Raut AA, Bichile LS, Chopra AR, et al, (abst) in Souvenir of ‘Amritbhallatak in Osteoarthritis: Exploratory Clinical Study’ in second World Ayurveda Congress held at Pune on 11th November 2006.
  117. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32 week randomized, placebo – controlled clinical evaluation of RA-11, an ayurvedic drug, on osteoarthritis of the knees. Journal of Clinical Rheumatology. 2004;10:236–245
  118. Spigelblatt L, Lainé-Ammara G, Pless IB, Guyver A. The use of alternative medicine by children. Pediatrics. 1994;94:811–814
  119. Feinglass J, Lee C, Rogers M, et al. Complementary and alternative medicine use for arthritis pain in 2 Chicago community areas. The Clinical Journal of Pain. 2007;23:744–749
  120. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis and Rheumatism. 2005;53:748–755
  121. Rao JK, Kroenke K, Mihaliak KA, et al. Rheumatology patients' use of complementary therapies: results from a one-year longitudinal study. Arthritis and Rheumatism. 2003;49:619–625
  122. Kaboli PJ, Doebbeling BN, Saag KG, Rosenthal GE. Use of complementary and alternative medicine by older patients with arthritis: a population-based study. Arthritis and Rheumatism. 2001;45:398–403
  123. Rao JK, Mihaliak K, Kroenke K, et al. Use of complementary therapies for arthritis among patients of rheumatologists. Annals of Internal Medicine. 1999;131:409–416
  124. Alvarez-Nemegyei J, Bautista-Botello A. Association of complementary or alternative therapy use with quality of life, functional status or cumulated damage in chronic rheumatic diseases. Clinical Rheumatology. 2007;2:45
  125. Kestin M, Miller L, Littlejohn G, Wahlqvist M. The use of unproven remedies for rheumatoid arthritis in Australia. Medical Journal of Australia. 1985;143:516–518
  126. Vecchio PC. Attitudes to alternative medicine by rheumatology outpatient attenders. The Journal of Rheumatology. 1994;21:145–147
  127. Buchbinder R, Gingold M, Hall S, Cohen M. Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Internal Medicine Journal. 2002;32:208–214
  128. Rainer F, Ulreich A, Pfeiffer KP. Art und ausmaß der selbstmedikation mit sogenannten hausmitteln' bei patienten mit rheumatischen erkrankungen. Zeitschrift für Rheumatologie. 1982;41:276–279

PII: S1521-6942(08)00052-1

doi: 10.1016/j.berh.2008.05.001

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 4 , Pages 741-757 , August 2008

Article Tools

* Image Usage & Resolution